Source: Eur Respir J 2011; 37: 1378-1385
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Brodlie M., McKean M.C., Johnson G.E., Anderson A.E., Hilkens C.M.U., Fisher A.J., Corris P.A., Lordan J.L., Ward C.. Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease. Eur Respir J 2011; 37: 1378-1385

Member's Comments

No comment yet.

Related content which might interest you: Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis Source: Eur Respir J 2009; 34: 655 Year: 2009 Anti-inflammatory cytokines in cystic fibrosis lung disease Source: Eur Respir J 2006; 28: 581-587 Year: 2006 M2 polarized alveolar macrophages in pulmonary fibrosis Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease Source: Eur Respir J 2006 Oct 01;28(4):824-831 Year: 2006 Characterization of cystic fibrosis airway epithelium in vitro Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Circulating inflammatory cytokines in adult cystic fibrosis patients Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Decreased expression of HLA-DQ and -DR on blood monocytes, sputum macrophages and monocyte-derived macrophages in patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 The cytokine interleukin-17 is raised in the airway of people with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 The role of chemokines and cytokines in lung fibrosis Source: Eur Respir Rev 2008; 17: 151-156 Year: 2008 The chemokine decoy PA401 decreases interleukin-8 and chemotactic activity of cystic fibrosis airway samples Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Pro-inflammatory cytokines in cystic fibrosis lungs Source: Eur Respir J 2005; 26: Suppl. 49, 403s Year: 2005 Increased CCL18 production in interstitial lung diseases is associated with fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 CCL22 and CCL17 in rat radiation pneumonitis and in human idiopathic pulmonary fibrosis Source: Eur Respir J 2004; 24: 49-56 Year: 2004 Role of TGF-beta and IFN-gamma in interstitial pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 719s Year: 2004 Circulating monocytes from interstitial lung disease patients show an activated phenotype Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Lung CD4+ T-cells in patients with lung fibrosis produce pro-fibrotic interleukin-13 together with interferon-? Source: Eur Respir J, 57 (3) 2000983; 10.1183/13993003.00983-2020 Year: 2021 Role of macrophage activation in type II alveolar cells transplantation for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Treg depletion reduces bleomycin-induced pulmonary fibrosis by inducing Th17 and other CD4+T cell subset responses in lung Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016